Gilead Sciences
Finanzas
Cuenta de resultados
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Ebitda | 12.021,0 | 13.454,0 | 14.577,0 |
| EBIT | 11.817,0 | 10.687,0 | 9.328,0 |
| Impuestos | 1.286,0 | 211,00 | 1.247,0 |
| Beneficio neto | 5.665,0 | 480,00 | 8.510,0 |
| Beneficio por acción (Importe) | 4,5392 | 0,3849 | 6,8408 |
| Nota: Cifras en millones. | |||
Activo
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Efectivo y equivalentes | 7.564,0 | 9.991,0 | 6.085,0 |
| Cuentas a cobrar | 4.913,0 | 4.420,0 | 4.660,0 |
| Existencias | 1.774,0 | 1.710,0 | 1.787,0 |
| Total activo corriente | 18.342,0 | 19.173,0 | 16.085,0 |
| Inmovilizado | 6.138,0 | 5.929,0 | 5.898,0 |
| Fondo de comercio | 8.314,0 | 8.314,0 | 8.314,0 |
| Otro activo no corriente | 3.534,0 | 2.540,0 | 3.555,0 |
| Activos totales | 59.023,0 | 58.995,0 | 62.125,0 |
| Nota: Cifras en millones. | |||
Pasivo
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Pasivo corriente | 36.405,0 | 39.749,0 | 39.376,0 |
| Deuda a largo plazo | 22.129,0 | 24.896,0 | 23.189,0 |
| Otro pasivo no corriente | 1.558,0 | 1.627,0 | 2.773,0 |
| Fondos propios | 22.702,0 | 19.330,0 | 22.833,0 |
| Deuda neta | 16.145,0 | 15.754,0 | 12.954,0 |
| Nota: Cifras en millones. | |||
Ratios
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Dividendo por acción (Importe) | 3,0000 | 3,0800 | 3,1600 |
| Pay out (%) | 0,6609% | 8,0016% | 0,4619% |
| PER (veces) | 21,427 | 22,568 | 34,595 |
| Valor en libros por acción (Importe) | 18,325 | 15,513 | 18,293 |
| Flujo de caja por acción (Importe) | 6,3640 | 8,6278 | 7,9832 |
| Capitaliación de mercado (Mill.) | 103.720,5 | 115.117,5 | 189.303,9 |
| Empleados | 18.000,0 | 17.600,0 | 17.000,0 |
| Nota: Datos en euros | |||
| Nota: Los datos del año actual y los próximos son estimaciones de S&P Global. | |||